Listen to ASX-listed Proteomics MD, Dr Richard Lipscombe as he chats to Matt Birney on the Bulls N’ Bears Small Cap Wrap about Proteomic’s clinical trial for its blood test that can predict the onset of diabetic kidney disease 4 years out.

<p>Listen to ASX-listed Proteomics MD, Dr Richard Lipscombe as he chats to Matt Birney on the Bulls N&rsquo; Bears Small Cap Wrap about Proteomic&rsquo;s clinical trial for its blood test that can predict the onset of diabetic kidney disease 4 years out.</p>

Matt Birney and Bulls N' Bears sit at the epicentre of the small cap ASX-listed company space in Perth and Western Australia. Bulls N’ Bears covers public company news, views and CEO interviews across a number of main stream media platforms in WA. Its financial markets followers, who come from all four corners of the globe, are looking to zero in on Western Australia’s unique international status as the most prolific developer of small capped publicly listed companies in the world.

<p>Matt Birney and Bulls N' Bears sit at the epicentre of the small cap ASX-listed company space in Perth and Western Australia. Bulls N&rsquo; Bears covers public company news, views and CEO interviews across a number of main stream media platforms in WA. Its financial markets followers, who come from all four corners of the globe, are looking to zero in on Western Australia&rsquo;s unique international status as the most prolific developer of small capped publicly listed companies in the world.</p>

Advertisement